-
Study aim
-
Evaluation the effectiveness of Vitamin C on the level of Total Antioxidant Capacity (TAC) in bruxism patients
-
Design
-
This clinical trial with a sample size of 30 people was a three-phase, double-blind study with parallel groups. Block randomization was performed in six-piece block individually by a sealed envelope. The random sequence was determined by draw.
-
Settings and conduct
-
The study population was patients with bruxism of Dentistry Faculty of Tehran University of Medical Sciences in international campus branch. After the examination, completing the questionnaire, and evaluating the patients’ pain severity by numerical rating scale, 1 mm non- excitatory and excitatory saliva was collected from the patients. Then, 250 mg vitamin C was prescribed for the intervention group and one daily was given to the placebo control group. Eventually, after a month, their pain was measured and their excitatory and non- excitatory saliva was collected.In order to blinding, the medications were put into boxes of one color and one form, and the difference was the code on which they were inserted; the list was kept by clinical caregiver until decoded. The patient,researcher, outcome evaluator, and data analyzer are kept compared to the blinded study groups.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: symptoms of grinding teeth on each other, discomfort and fatigue, increase in the size of masticatory muscles. toothpicking, recurrent migraines ,broken dental fillings or splint, ulceration of denture underlying mucosa and sensitivity to percussion. Exclusion criteria: consumption of alcohol and cigarettes and specific medications, systemic problems (diseases of kidney and liver, thyroid and diabetes) and cancer
-
Intervention groups
-
This study was conducted on a control group of 15 patients with placebo and the intervention group of 15 patients with vitamin C.
-
Main outcome variables
-
Total Antioxidant Capacity of stimulated and unstimulated saliva of patient